Abstract:
The invention relates to a system for predicting the viability of a body tissue in a patient. The system comprises a computing device, and a first pressure measuring device for measuring local perfusion pressure in the body tissue of the patient. This measuring device is connected to the computing device. A second pressure measuring device is provided for measuring the systemic perfusion pressure of the patient, said second pressure measuring device being connected to the computing device. A feedback indicator is connected to the computing device and is adapted to indicate the viability of the tissue calculated by the computing device on the basis of the measured local and systemic perfusion pressures. The invention also includes a method of predicting the viability of the body tissue and to the first pressure measuring device.
Abstract:
The invention relates to a method, system and computer readable medium for determining a strabismus angle of the eyes of an individual by: positioning the individual with his or her eyes in front of an eye tracker device and in front of a screen at a viewing distance; displaying a small image element on the screen; measuring a position and line of sight of the eyes of the individual with the eye tracker device while the individual is focussing on the small image element; forwarding the measured position and line of sight of the eyes from the eye tracker device to a computer system; and, calculating the strabismus angle between the eyes by calculating the difference in line of sight of the left and right eyes of the individual.
Abstract:
The present disclosure relates to a method for producing a composition, wherein the method comprises the steps of co-culturing immortalized fibroblasts and immortalized keratinocytes, thereby producing secretion; separating the secretion from the fibroblasts and keratinocytes; and providing a pharmaceutically acceptable composition comprising the secretion. The present disclosure also relates to the composition obtainable by the method, wherein the composition preferably is a pharmaceutical composition for medical use, preferably for use in the treatment of a wound, preferably a chronic or acute wound.
Abstract:
The present invention provides a kit for use for the implantation of a dental implant, comprising an implant guide comprising a proximal end and a distal end, wherein the distal end is configured to be detachably attached to a dental implant, said implant guide comprising a cylindrical body, wherein the cylindrical body comprises a cylindrical outer surface and a circumferential groove in the outer surface, and a template configured to be arranged at a predetermined location with respect to a jaw, wherein the template comprises at least one implantation channel to guide the cylindrical body of the implant guide in a desired implantation direction during implantation of a dental implant in the jaw, and a stop surface at an end of the implantation channel. The kit comprises a stop element comprising a first part and a second part, wherein the first part and the second part are configured to be movable between a first state, in which the first part and the second part are spaced at a first distance, and a second state, in which the first part and the second part are spaced at a second distance, wherein the first distance is smaller than the second distance, and wherein the first and second parts are biased to the first state, wherein the second distance is the same or larger than a distance between diametrically opposite sides of the outer surface of the implant guide, such that, before implantation, the first part and the second part can be arranged, in the second state, on diametrically opposite sides of the outer surface, and that during movement in the implantation direction of the dental implant into the jaw, the stop surface of the implantation channel will push the stop element towards the groove until the groove will allow the first and second part to move towards the first state and the stop element will be caught by the groove, therewith blocking further movement of the implant guide in the implantation direction.
Abstract:
Methods of diagnosing colorectal cancer and precursors thereof using miRNA biomarkers are disclosed, together with kits and devices for detecting the biomarkers, and uses of the biomarkers. The biomarkers described are reliably detected in stool and demonstrate significantly different expression levels in colorectal cancer patients when compared to colorectal cancer negative patients.
Abstract:
The present invention relates to methods and kits for classifying an individual as being afflicted with frontotemporal dementia (FTD). The invention further relates to the discrimination between different subtypes of FTD.
Abstract:
The present invention relates to methods and kits for classifying an individual as being afflicted with frontotemporal dementia (FTD). The invention further relates to the discrimination between different subtypes of FTD.
Abstract:
A transducer for use in a capacitive vibration sensor comprises a mass- spring system (3) and a first flat plate. The mass-spring system comprises a flat central proof mass (4), a surrounding support structure (5), and at least three interleaved spiral-shaped spring arms (6, 7, 8). The first flat plate is mounted at a first fixed position relative to the surrounding support structure, spaced from, and parallel to a first flat side (41) of the flat central proof mass. The flat central proof mass and the first flat plate are forming a first electric capacitance. Externally caused accelerations of the surrounding support structure cause parallel displacement of the flat central proof mass relative to the first flat plate, resulting in a changing first capacity of the first electric capacitance.
Abstract:
The invention relates to treatments for depressive disorders based on reducing the extracellular matrix in the hippocampus. The invention also relates to methods of screening for new compounds to treat depressive disorders.
Abstract:
The invention relates to the use of a gene or a gene product as a target for identifying a pharmacologically active compound, preferably for sensitizing a cancer cell for ionizing radiation. The invention further relates to methods for determining whether a compound is capable of sensitizing a cancer cell for ionizing radiation and to methods for increasing the susceptibility of a cell to radiation. Additionally, the invention related to a compound for use in the treatment of an individual suffering from cancer, preferably wherein said treatment comprises irradiating said individual or part thereof with ionizing radiation. Furthermore, the invention relates to methods for determining the radiation sensitivity of a cancer in an individual. The preferred target of radiosensitization is GPR27.